| Year |
Citation |
Score |
| 2022 |
Kumar V, Rosenzweig R, Asalla S, Nehra S, Prabhu SD, Bansal SS. TNFR1 Contributes to Activation-Induced Cell Death of Pathological CD4 T Lymphocytes During Ischemic Heart Failure. Jacc. Basic to Translational Science. 7: 1038-1049. PMID 36337927 DOI: 10.1016/j.jacbts.2022.05.005 |
0.325 |
|
| 2022 |
Kumar V, Prabhu SD, Bansal SS. CD4 T-lymphocytes exhibit biphasic kinetics post-myocardial infarction. Frontiers in Cardiovascular Medicine. 9: 992653. PMID 36093172 DOI: 10.3389/fcvm.2022.992653 |
0.32 |
|
| 2019 |
Kumar V, Torben W, Mansfield J, Alvarez X, Vande Stouwe C, Li J, Byrareddy SN, Didier PJ, Pahar B, Molina PE, Mohan M. Cannabinoid Attenuation of Intestinal Inflammation in Chronic SIV-Infected Rhesus Macaques Involves T Cell Modulation and Differential Expression of Micro-RNAs and Pro-inflammatory Genes. Frontiers in Immunology. 10: 914. PMID 31114576 DOI: 10.3389/Fimmu.2019.00914 |
0.322 |
|
| 2015 |
Tu TC, Brown NK, Kim TJ, Wroblewska J, Yang X, Guo X, Lee SH, Kumar V, Lee KM, Fu YX. CD160 is essential for NK-mediated IFN-γ production. The Journal of Experimental Medicine. 212: 415-29. PMID 25711213 DOI: 10.1084/Jem.20131601 |
0.486 |
|
| 2015 |
Georgoudaki AM, Khodabandeh S, Puiac S, Persson CM, Larsson MK, Lind M, Hammarfjord O, Nabatti TH, Wallin RP, Yrlid U, Rhen M, Kumar V, Chambers BJ. CD244 is expressed on dendritic cells and regulates their functions. Immunology and Cell Biology. 93: 581-90. PMID 25643613 DOI: 10.1038/Icb.2014.124 |
0.474 |
|
| 2014 |
Kim TJ, Kim M, Kim HM, Lim SA, Kim EO, Kim K, Song KH, Kim J, Kumar V, Yee C, Doh J, Lee KM. Homotypic NK cell-to-cell communication controls cytokine responsiveness of innate immune NK cells. Scientific Reports. 4: 7157. PMID 25475707 DOI: 10.1038/Srep07157 |
0.5 |
|
| 2014 |
Kim TJ, Upadhyay V, Kumar V, Lee KM, Fu YX. Innate lymphoid cells facilitate NK cell development through a lymphotoxin-mediated stromal microenvironment. The Journal of Experimental Medicine. 211: 1421-31. PMID 24913234 DOI: 10.1084/Jem.20131501 |
0.481 |
|
| 2014 |
Noh KH, Kim SH, Kim JH, Song KH, Lee YH, Kang TH, Han HD, Sood AK, Ng J, Kim K, Sonn CH, Kumar V, Yee C, Lee KM, Kim TW. API5 confers tumoral immune escape through FGF2-dependent cell survival pathway. Cancer Research. 74: 3556-66. PMID 24769442 DOI: 10.1158/0008-5472.Can-13-3225 |
0.326 |
|
| 2014 |
Lee JE, Lim SA, Kim TJ, Kim K, Ng J, Kim YH, Jang IJ, Oh SB, Lee JC, Yee C, Kumar V, Lee KM. NKG2D ligation relieves 2B4-mediated NK-cell self-tolerance in mice. European Journal of Immunology. 44: 1802-13. PMID 24610736 DOI: 10.1002/Eji.201343724 |
0.518 |
|
| 2013 |
Lim SA, Kim TJ, Lee JE, Sonn CH, Kim K, Kim J, Choi JG, Choi IK, Yun CO, Kim JH, Yee C, Kumar V, Lee KM. Ex vivo expansion of highly cytotoxic human NK cells by cocultivation with irradiated tumor cells for adoptive immunotherapy. Cancer Research. 73: 2598-607. PMID 23580577 DOI: 10.1158/0008-5472.Can-12-2893 |
0.496 |
|
| 2012 |
Waggoner SN, Kumar V. Evolving role of 2B4/CD244 in T and NK cell responses during virus infection. Frontiers in Immunology. 3: 377. PMID 23248626 DOI: 10.3389/Fimmu.2012.00377 |
0.495 |
|
| 2011 |
Zloza A, Lyons GE, Chlewicki LK, Kohlhapp FJ, O'Sullivan JA, Lacek AT, Moore TV, Jagoda MC, Kumar V, Guevara-Patiño JA. Engagement of NK receptor NKG2D, but not 2B4, results in self-reactive CD8+ T cells and autoimmune vitiligo. Autoimmunity. 44: 599-606. PMID 21913803 DOI: 10.3109/08916934.2011.593599 |
0.477 |
|
| 2010 |
Kim EO, Kim TJ, Kim N, Kim ST, Kumar V, Lee KM. Homotypic cell to cell cross-talk among human natural killer cells reveals differential and overlapping roles of 2B4 and CD2. The Journal of Biological Chemistry. 285: 41755-64. PMID 20813844 DOI: 10.1074/Jbc.M110.137976 |
0.495 |
|
| 2010 |
Kim EO, Kim N, Kim TJ, Kim K, Kim TW, Kumar V, Lee KM. Unidirectional signaling triggered through 2B4 (CD244), not CD48, in murine NK cells Journal of Leukocyte Biology. 88: 707-714. PMID 20647560 DOI: 10.1189/Jlb.0410198 |
0.547 |
|
| 2010 |
Waggoner SN, Taniguchi RT, Mathew PA, Kumar V, Welsh RM. Absence of mouse 2B4 promotes NK cell-mediated killing of activated CD8+ T cells, leading to prolonged viral persistence and altered pathogenesis. The Journal of Clinical Investigation. 120: 1925-38. PMID 20440077 DOI: 10.1172/Jci41264 |
0.784 |
|
| 2010 |
Chlewicki LK, Kumar V. A model system for studying NK cell receptor signaling. Methods in Molecular Biology (Clifton, N.J.). 612: 177-98. PMID 20033641 DOI: 10.1007/978-1-60761-362-6_12 |
0.483 |
|
| 2010 |
Lian RH, Kumar V. Use of Stem Cell Radiation Chimeras to Analyze How Domains of Specific Proteins Impact on Murine NK Cell Development In Vivo Methods of Molecular Biology. 612: 51-65. PMID 20033634 DOI: 10.1007/978-1-60761-362-6_5 |
0.424 |
|
| 2009 |
Yang D, Wang S, Brooks C, Dong Z, Schoenlein PV, Kumar V, Ouyang X, Xiong H, Lahat G, Hayes-Jordan A, Lazar A, Pollock R, Lev D, Liu K. IFN regulatory factor 8 sensitizes soft tissue sarcoma cells to death receptor-initiated apoptosis via repression of FLICE-like protein expression. Cancer Research. 69: 1080-8. PMID 19155307 DOI: 10.1158/0008-5472.Can-08-2520 |
0.305 |
|
| 2009 |
Kumar V, Chapman JR. Evaluation of Stem Cell Concentrate Prepared From Bone Marrow Aspirate Using the Res-Q TM system. Blood. 114: 4232-4232. DOI: 10.1182/Blood.V114.22.4232.4232 |
0.383 |
|
| 2008 |
Chlewicki LK, Velikovsky CA, Balakrishnan V, Mariuzza RA, Kumar V. Molecular basis of the dual functions of 2B4 (CD244). Journal of Immunology (Baltimore, Md. : 1950). 180: 8159-67. PMID 18523281 DOI: 10.4049/Jimmunol.180.12.8159 |
0.483 |
|
| 2007 |
Velikovsky CA, Deng L, Chlewicki LK, Fernández MM, Kumar V, Mariuzza RA. Structure of natural killer receptor 2B4 bound to CD48 reveals basis for heterophilic recognition in signaling lymphocyte activation molecule family. Immunity. 27: 572-84. PMID 17950006 DOI: 10.1016/J.Immuni.2007.08.019 |
0.496 |
|
| 2007 |
Taniguchi RT, Guzior D, Kumar V. 2B4 inhibits NK-cell fratricide. Blood. 110: 2020-3. PMID 17537992 DOI: 10.1182/Blood-2007-02-076927 |
0.786 |
|
| 2006 |
McNerney ME, Lee KM, Zhou P, Molinero L, Mashayekhi M, Guzior D, Sattar H, Kuppireddi S, Wang CR, Kumar V, Alegre ML. Role of natural killer cell subsets in cardiac allograft rejection. American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons. 6: 505-13. PMID 16468959 DOI: 10.1111/J.1600-6143.2005.01226.X |
0.73 |
|
| 2006 |
McNerney ME, Kumar V. The CD2 family of natural killer cell receptors. Current Topics in Microbiology and Immunology. 298: 91-120. PMID 16323413 DOI: 10.1007/3-540-27743-9_5 |
0.724 |
|
| 2006 |
Lee KM, Forman JP, McNerney ME, Stepp S, Kuppireddi S, Guzior D, Latchman YE, Sayegh MH, Yagita H, Park CK, Oh SB, Wülfing C, Schatzle J, Mathew PA, Sharpe AH, ... Kumar V, et al. Requirement of homotypic NK-cell interactions through 2B4(CD244)/CD48 in the generation of NK effector functions. Blood. 107: 3181-8. PMID 15905190 DOI: 10.1182/Blood-2005-01-0185 |
0.749 |
|
| 2005 |
McNerney ME, Guzior D, Kumar V. 2B4 (CD244)-CD48 interactions provide a novel MHC class I-independent system for NK-cell self-tolerance in mice. Blood. 106: 1337-40. PMID 15870174 DOI: 10.1182/Blood-2005-01-0357 |
0.744 |
|
| 2005 |
Kumar V, McNerney ME. A new self: MHC-class-I-independent natural-killer-cell self-tolerance. Nature Reviews. Immunology. 5: 363-74. PMID 15841099 DOI: 10.1038/Nri1603 |
0.697 |
|
| 2005 |
Vaidya SV, Stepp SE, McNerney ME, Lee JK, Bennett M, Lee KM, Stewart CL, Kumar V, Mathew PA. Targeted disruption of the 2B4 gene in mice reveals an in vivo role of 2B4 (CD244) in the rejection of B16 melanoma cells. Journal of Immunology (Baltimore, Md. : 1950). 174: 800-7. PMID 15634901 DOI: 10.4049/Jimmunol.174.2.800 |
0.74 |
|
| 2005 |
McNerney ME, Lee KM, Kumar V. 2B4 (CD244) is a non-MHC binding receptor with multiple functions on natural killer cells and CD8+ T cells. Molecular Immunology. 42: 489-94. PMID 15607804 DOI: 10.1016/J.Molimm.2004.07.032 |
0.757 |
|
| 2004 |
Lian RH, Chin RK, Nemeth HE, Libby SL, Fu YX, Kumar V. A role for lymphotoxin in the acquisition of Ly49 receptors during NK cell development. European Journal of Immunology. 34: 2699-707. PMID 15368286 DOI: 10.1002/Eji.200425394 |
0.423 |
|
| 2004 |
Karandikar NJ, Kroft SH, Yegappan S, Rogers BB, Aquino VM, Lee KM, Kumar V, Guenaga FJ, Jaffe ES, Douek DC, McKenna RW. Unusual immunophenotype of CD8+ T cells in familial hemophagocytic lymphohistiocytosis Blood. 104: 2007-2009. PMID 15205266 DOI: 10.1182/Blood-2004-04-1431 |
0.439 |
|
| 2004 |
Lee KM, McNerney ME, Stepp SE, Mathew PA, Schatzle JD, Bennett M, Kumar V. 2B4 acts as a non-major histocompatibility complex binding inhibitory receptor on mouse natural killer cells. The Journal of Experimental Medicine. 199: 1245-54. PMID 15123744 DOI: 10.1084/Jem.20031989 |
0.756 |
|
| 2003 |
Catalina F, Milewich L, Kumar V, Bennett M. Dietary dehydroepiandrosterone inhibits bone marrow and leukemia cell transplants: role of food restriction. Experimental Biology and Medicine. 228: 1303-1320. PMID 14681546 DOI: 10.1177/153537020322801109 |
0.341 |
|
| 2003 |
Kawamura T, Koka R, Ma A, Kumar V. Differential Roles for IL-15R α-Chain in NK Cell Development and Ly-49 Induction Journal of Immunology. 171: 5085-5090. PMID 14607906 DOI: 10.4049/Jimmunol.171.10.5085 |
0.339 |
|
| 2003 |
Lee KM, Bhawan S, Majima T, Wei H, Nishimura MI, Yagita H, Kumar V. Cutting edge: the NK cell receptor 2B4 augments antigen-specific T cell cytotoxicity through CD48 ligation on neighboring T cells. Journal of Immunology (Baltimore, Md. : 1950). 170: 4881-5. PMID 12734329 DOI: 10.4049/Jimmunol.170.10.4881 |
0.522 |
|
| 2002 |
Lian RH, Kumar V. Murine natural killer cell progenitors and their requirements for development Seminars in Immunology. 14: 453-460. PMID 12457618 DOI: 10.1016/S1044532302000805 |
0.436 |
|
| 2002 |
Morris MA, Koulich E, Liu J, Arora V, George TC, Schatzle JD, Kumar V, Bennett M. Definition of additional functional ligands for Ly49I(B6) using FVBLy49I(B6) transgenic mice and B6 natural killer cell effectors. Transplantation. 74: 1449-54. PMID 12451247 DOI: 10.1097/00007890-200211270-00018 |
0.431 |
|
| 2002 |
Kouro T, Kumar V, Kincade PW. Relationships between early B- and NK-lineage lymphocyte precursors in bone marrow. Blood. 100: 3672-80. PMID 12393656 DOI: 10.1182/Blood-2002-02-0653 |
0.486 |
|
| 2002 |
Morris MA, Liu J, Arora V, George TC, Klem J, Schatzle JD, Kumar V, Bennett M. B6 strain Ly49I inhibitory gene expression on T cells in FVB.Ly49IB6 transgenic mice fails to prevent normal T cell functions. Journal of Immunology (Baltimore, Md. : 1950). 169: 3661-6. PMID 12244158 DOI: 10.4049/Jimmunol.169.7.3661 |
0.466 |
|
| 2002 |
Klem J, Verrett PC, Kumar V, Schatzle JD. 2B4 Is Constitutively Associated with Linker for the Activation of T Cells in Glycolipid-Enriched Microdomains: Properties Required for 2B4 Lytic Function Journal of Immunology. 169: 55-62. PMID 12077228 DOI: 10.4049/Jimmunol.169.1.55 |
0.442 |
|
| 2001 |
Taylor MA, Chaudhary PM, Klem J, Kumar V, Schatzle JD, Bennett M. Inhibition of the Death Receptor Pathway by cFLIP Confers Partial Engraftment of MHC Class I-Deficient Stem Cells and Reduces Tumor Clearance in Perforin-Deficient Mice Journal of Immunology. 167: 4230-4237. PMID 11591744 DOI: 10.4049/Jimmunol.167.8.4230 |
0.447 |
|
| 2001 |
Boles KS, Stepp SE, Bennett M, Kumar V, Mathew PA. 2B4 (CD244) and CS1: novel members of the CD2 subset of the immunoglobulin superfamily molecules expressed on natural killer cells and other leukocytes. Immunological Reviews. 181: 234-49. PMID 11513145 DOI: 10.1034/J.1600-065X.2001.1810120.X |
0.528 |
|
| 2000 |
Kumaresan PR, Stepp SE, Verrett PC, Chuang SS, Boles KS, Lai WC, Ryan JC, Bennett M, Kumar V, Mathew PA. Molecular characterization of the rat NK cell receptor 2B4. Molecular Immunology. 37: 735-44. PMID 11275258 DOI: 10.1016/S0161-5890(00)00103-6 |
0.497 |
|
| 2000 |
Sayós J, Nguyen KB, Wu C, Stepp SE, Howie D, Schatzle JD, Kumar V, Biron CA, Terhorst C. Potential pathways for regulation of NK and T cell responses: differential X-linked lymphoproliferative syndrome gene product SAP interactions with SLAM and 2B4. International Immunology. 12: 1749-57. PMID 11099315 DOI: 10.1093/Intimm/12.12.1749 |
0.502 |
|
| 2000 |
Austin Taylor M, Bennett M, Kumar V, Schatzle JD. Functional defects of NK cells treated with chloroquine mimic the lytic defects observed in perforin-deficient mice. Journal of Immunology (Baltimore, Md. : 1950). 165: 5048-53. PMID 11046034 DOI: 10.4049/Jimmunol.165.9.5048 |
0.429 |
|
| 2000 |
Stepp SE, Mathew PA, Bennett M, De Saint Basile G, Kumar V. Perforin: More than just an effector molecule Immunology Today. 21: 254-256. PMID 10825735 DOI: 10.1016/S0167-5699(00)01622-4 |
0.329 |
|
| 2000 |
Liu J, Morris MA, Nguyen P, George TC, Koulich E, Lai WC, Schatzle JD, Kumar V, Bennett M. Ly49I NK cell receptor transgene inhibition of rejection of H2(b) mouse bone marrow transplants Journal of Immunology. 164: 1793-1799. PMID 10657626 DOI: 10.4049/Jimmunol.164.4.1793 |
0.402 |
|
| 1997 |
Liu J, Sentman CL, Kumar V, Bennett M. Murine marrow coexpressing H2-Dsp2 and H2-Db on host natural killer cell rejection. Transplantation. 63: 444-9. PMID 9039937 DOI: 10.1097/00007890-199702150-00019 |
0.393 |
|
| 1990 |
Sentman CL, Hackett J, Moore TA, Tutt MM, Bennett M, Kumar V. Pan natural killer cell monoclonal antibodies and their relationship to the NK1.1 antigen. Hybridoma. 8: 605-14. PMID 2613267 DOI: 10.1089/Hyb.1989.8.605 |
0.405 |
|
| 1984 |
Lust JA, Bennett M, Kumar V. Lysis of FLD-3 Friend erythroleukemia cells in vitro and in vivo: effect of 89Sr treatment and Friend virus infection. International Journal of Cancer. 33: 107-113. PMID 6582049 DOI: 10.1002/Ijc.2910330117 |
0.437 |
|
| 1979 |
Kumar V, Bennett M. Immunosuppression by friend leukemia virus is h-2 restricted by alloreactive t lymphocytes. Proceedings of the National Academy of Sciences of the United States of America. 76: 2415-2419. PMID 313055 DOI: 10.1073/Pnas.76.5.2415 |
0.376 |
|
| 1975 |
Kumar V, Bennett M. Brief Communication: Loss of Marrow Allograft Resistance in Mice With TransplantedMethylcholanthrene-Induced Sarcomas Journal of the National Cancer Institute. 55: 489-492. DOI: 10.1093/Jnci/55.2.489 |
0.407 |
|
| Show low-probability matches. |